NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.44
-1.81 (-4.99%)
At close: Apr 14, 2026, 4:00 PM EDT
34.50
+0.06 (0.17%)
After-hours: Apr 14, 2026, 5:06 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $3.96 billion as of April 14, 2026. Its market cap has increased by 60.90% in one year.
Market Cap
3.96B
Enterprise Value
3.26B
1-Year Change
60.90%
Ranking
Category
Stock Price
$34.44
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.96B, an increase of 2,463.79%. That is a compound annual growth rate of 87.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 4.17B | 4.78% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 4.63B |
| Amicus Therapeutics | 4.54B |
| Crinetics Pharmaceuticals | 4.16B |
| Viking Therapeutics | 4.12B |
| Travere Therapeutics | 3.89B |
| Structure Therapeutics | 3.77B |
| ACADIA Pharmaceuticals | 3.75B |
| Telix Pharmaceuticals | 3.74B |